NCT00473278
Completed
Not Applicable
Analysis of Human Tear Proteins in Children: A Pilot Study to Describe the Tear Film Proteome of Pediatric Patients Undergoing Ophthalmic Examination.
ConditionsEye Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Eye Disease
- Sponsor
- University of Colorado, Denver
- Enrollment
- 2
- Locations
- 1
- Primary Endpoint
- Proteome of Human Tears
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film, and any unique aspects of tears in children. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Less than 18 years of age
- •A parent or legal guardian provide written informed consent to participate
- •Able to cooperate with tear sample collection, or a previously planned sedation for other medical purposes
Exclusion Criteria
- •Age greater than or equal to 18 years
- •Patients' parents or legal guardians who refuse to sign study consent
Outcomes
Primary Outcomes
Proteome of Human Tears
Time Frame: Single Exam
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
Pilot Study of Human Tear ProteinsEye DiseaseNCT00453258University of Colorado, Denver63
Completed
Phase 1
Analyzing the Composition of Tears to Identify CancerBreast CancerOvarian CancerColon CancerBenign DiseaseNCT00574678University of Arkansas150
Not yet recruiting
Phase 1
Clinical observation of artificial tears combined with Tuina in the treatment of dry eye diseasedry eye diseaseITMCTR2024000001Jiangsu Haibin Sanatorium
Unknown
Phase 4
Metabolomic Profile in Dry Eye Syndrome Patients.Dry Eye SyndromesCataractNCT05433428Ifocus Oyeklinikk250
Completed
Not Applicable
Multicenter Trial Evaluating Quality of Tears Produced by Nasal NeurostimulationDry Eye SyndromesNCT02385292Oculeve, Inc.23